C.R. Bard, Inc. (BCR) Stake Boosted by Wetherby Asset Management Inc.

Wetherby Asset Management Inc. raised its position in C.R. Bard, Inc. (NYSE:BCR) by 1.8% during the fourth quarter, Holdings Channel reports. The firm owned 2,584 shares of the company’s stock after buying an additional 46 shares during the period. Wetherby Asset Management Inc.’s holdings in C.R. Bard were worth $581,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in BCR. APG Asset Management N.V. increased its position in shares of C.R. Bard by 138.0% in the third quarter. APG Asset Management N.V. now owns 592,362 shares of the company’s stock worth $132,855,000 after buying an additional 343,449 shares during the period. BlackRock Fund Advisors increased its position in shares of C.R. Bard by 15.3% in the second quarter. BlackRock Fund Advisors now owns 2,175,495 shares of the company’s stock worth $511,589,000 after buying an additional 288,839 shares during the period. Standard Life Investments LTD increased its position in shares of C.R. Bard by 27.4% in the third quarter. Standard Life Investments LTD now owns 1,309,071 shares of the company’s stock worth $293,565,000 after buying an additional 281,458 shares during the period. Los Angeles Capital Management & Equity Research Inc. increased its position in shares of C.R. Bard by 303.2% in the second quarter. Los Angeles Capital Management & Equity Research Inc. now owns 294,872 shares of the company’s stock worth $69,342,000 after buying an additional 221,741 shares during the period. Finally, State of Tennessee Treasury Department increased its position in shares of C.R. Bard by 386.5% in the second quarter. State of Tennessee Treasury Department now owns 220,645 shares of the company’s stock worth $51,887,000 after buying an additional 175,296 shares during the period. 87.46% of the stock is currently owned by hedge funds and other institutional investors.

Institutional Ownership by Quarter for C.R. Bard (NYSE:BCR)

C.R. Bard, Inc. (NYSE:BCR) traded up 0.18% during midday trading on Friday, reaching $240.29. The company’s stock had a trading volume of 885,238 shares. The stock has a 50-day moving average price of $232.33 and a 200 day moving average price of $222.27. C.R. Bard, Inc. has a 12 month low of $184.59 and a 12 month high of $241.50. The company has a market cap of $17.67 billion, a PE ratio of 34.18 and a beta of 0.63.

C.R. Bard (NYSE:BCR) last posted its earnings results on Thursday, January 26th. The company reported $2.77 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $2.74 by $0.03. C.R. Bard had a net margin of 14.31% and a return on equity of 48.48%. The firm had revenue of $967.10 million for the quarter, compared to analysts’ expectations of $956.12 million. During the same quarter last year, the firm earned $2.43 EPS. The company’s quarterly revenue was up 10.0% compared to the same quarter last year. Analysts expect that C.R. Bard, Inc. will post $11.64 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which was paid on Friday, February 3rd. Shareholders of record on Monday, January 23rd were given a dividend of $0.26 per share. The ex-dividend date was Thursday, January 19th. This represents a $1.04 annualized dividend and a dividend yield of 0.43%. C.R. Bard’s dividend payout ratio is currently 14.77%.

COPYRIGHT VIOLATION NOTICE: This report was first posted by sleekmoney and is the sole property of of sleekmoney. If you are reading this report on another site, it was illegally copied and republished in violation of United States & international copyright & trademark law. The correct version of this report can be accessed at http://sleekmoney.com/c-r-bard-inc-bcr-stake-boosted-by-wetherby-asset-management-inc/1655977.html.

BCR has been the topic of a number of recent analyst reports. Morgan Stanley raised C.R. Bard from an “equal weight” rating to an “overweight” rating and boosted their price target for the stock from $240.00 to $260.00 in a research report on Tuesday, January 3rd. Zacks Investment Research raised C.R. Bard from a “hold” rating to a “buy” rating and set a $241.00 target price on the stock in a research report on Thursday, October 27th. BMO Capital Markets raised C.R. Bard from a “market perform” rating to an “outperform” rating and set a $240.00 target price on the stock in a research report on Wednesday, October 26th. They noted that the move was a valuation call. Raymond James Financial, Inc. raised C.R. Bard from an “outperform” rating to a “strong-buy” rating and upped their target price for the company from $250.00 to $265.00 in a research report on Thursday, January 5th. Finally, Barclays PLC reaffirmed a “hold” rating and issued a $245.00 target price on shares of C.R. Bard in a research report on Sunday, January 29th. Eight research analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has assigned a strong buy rating to the company. C.R. Bard currently has an average rating of “Buy” and an average target price of $244.14.

In other news, VP John A. Deford sold 15,883 shares of the firm’s stock in a transaction that occurred on Monday, December 12th. The shares were sold at an average price of $218.03, for a total transaction of $3,462,970.49. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Jim C. Beasley sold 8,593 shares of the firm’s stock in a transaction that occurred on Thursday, February 9th. The stock was sold at an average price of $239.58, for a total transaction of $2,058,710.94. Following the sale, the insider now owns 34,415 shares of the company’s stock, valued at approximately $8,245,145.70. The disclosure for this sale can be found here. In the last three months, insiders have sold 91,128 shares of company stock worth $21,043,269. Insiders own 0.97% of the company’s stock.

C.R. Bard Company Profile

C. R. Bard, Inc (Bard) and its subsidiaries are engaged in designing, manufacturing, packaging, distribution and sale of medical, surgical, diagnostic and patient care devices. The Company sells its products to hospitals, individual healthcare professionals, extended care facilities and alternate site facilities.

5 Day Chart for NYSE:BCR

Want to see what other hedge funds are holding BCR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for C.R. Bard, Inc. (NYSE:BCR).

This story was originally published by sleekmoney (http://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at http://sleekmoney.com/c-r-bard-inc-bcr-stake-boosted-by-wetherby-asset-management-inc/1655977.html

Receive News & Ratings for C.R. Bard Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for C.R. Bard Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

 

Leave a Reply

Your email address will not be published. Required fields are marked *